ALHC
Alignment Healthcare, Inc. Healthcare - Healthcare Plans Investor Relations →
Alignment Healthcare, Inc. (ALHC) closed at $17.34 as of 2026-03-20, trading 50.4% above its 200-week moving average of $11.53. The stock moved further from the line this week, up from 47.8% last week. The 14-week RSI sits at 44, indicating neutral momentum.
Trading volume is running at 1.7x of its 14-week average, which is in the normal range. The balance between buying and selling volume (1.00 ratio) is neutral — neither side is clearly dominating.
Over the past 212 weeks of data, ALHC has crossed below its 200-week moving average 3 times. On average, these episodes lasted 47 weeks. The average one-year return after crossing below was -1.7%, suggesting these dips have not historically been reliable buying opportunities for this stock.
With a market cap of $3.5 billion, ALHC is a mid-cap stock. The company generates a free cash flow yield of 3.5%. Return on equity stands at -0.7%. The stock trades at 19.8x book value.
Share count has increased 9.0% over three years, indicating dilution.
Over the past 4.2 years, a hypothetical investment of $100 in ALHC would have grown to $187, compared to $158 for the S&P 500. That represents an annualized return of 16.2% vs 11.5% for the index — confirming ALHC as a market-beating investment and the kind of quality company where buying during 200-week moving average touches has historically been rewarded.
Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: ALHC vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After ALHC Crosses Below the Line?
Across 3 historical episodes, buying ALHC when it crossed below its 200-week moving average produced an average return of -2.0% after 12 months (median -18.0%), compared to +8.7% for the S&P 500 over the same periods. 33% of those episodes were profitable after one year. After 24 months, the average return was -39.0% vs +33.5% for the index.
Each line shows $100 invested at the moment ALHC crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
ALHC has crossed below its 200-week MA 3 times with an average 1-year return of +-1.7% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Feb 2022 | Aug 2022 | 22 | 48.9% | -18.2% | +86.7% |
| Aug 2022 | Oct 2024 | 115 | 63.2% | -58.4% | +17.8% |
| Dec 2024 | Dec 2024 | 4 | 7.5% | +71.6% | +52.2% |
| Average | 47 | — | +-1.7% | — |
Frequently Asked Questions
Is ALHC below its 200-week moving average?
No. Alignment Healthcare, Inc. (ALHC) is currently 50.4% above its 200-week moving average of $11.53. It would need to fall to $11.53 to cross below the line.
What is ALHC's 200-week moving average price?
Alignment Healthcare, Inc.'s 200-week moving average is $11.53 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when ALHC drops below its 200-week moving average?
ALHC has crossed below its 200-week moving average 3 times in our data. The average one-year return after these crossings was -1.7%, meaning the dips were not reliable buying signals for this particular stock. These episodes lasted 47 weeks on average.
Is ALHC a good value right now?
Here's what our data says about ALHC as of 2026-03-20: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 44. Free cash flow yield is 3.5%. Return on equity is -0.7%. Price-to-book is 19.8x. This is not a buy or sell recommendation — always do your own research.
How does ALHC compare to the S&P 500?
Over the past 4.2 years, $100 invested in ALHC would have grown to $187, compared to $158 for the S&P 500. That's 16.2% annualized vs 11.5% for the index. ALHC has outperformed the broader market over this period.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-03-20